Sutro Biopharma Inc
NASDAQ:STRO

Watchlist Manager
Sutro Biopharma Inc Logo
Sutro Biopharma Inc
NASDAQ:STRO
Watchlist
Price: 1.93 USD 3.21% Market Closed
Market Cap: 159.1m USD
Have any thoughts about
Sutro Biopharma Inc?
Write Note

Sutro Biopharma Inc
Investor Relations

Sutro Biopharma Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. The company is headquartered in South San Francisco, California and currently employs 224 full-time employees. The company went IPO on 2018-09-27. The company is focused on deploying its integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF, to create a variety of protein therapeutics, initially for cancer. The company is engaged in designing therapeutics using potent modalities, including cytokine-based therapeutics, immuno-oncology agents, antibody-drug conjugates (ADCs) and bispecific antibodies that are directed against clinically validated targets. Its product candidate includes STRO-002 and STRO-001. STRO-002, is an ADC directed against folate receptor-alpha, for patients with FolRα-expressing cancers, such as ovarian and endometrial cancers. STRO-001, is an ADC directed against CD74, for patients with B-cell malignancies, such as multiple myeloma and non-Hodgkin lymphoma. Its product candidates are designed and optimized for therapeutic index by placing linker-warheads at specific locations within the antibody.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. William J. Newell J.D.
CEO & Director
No Bio Available
Dr. Hans-Peter Gerber Ph.D.
Chief Scientific Officer
No Bio Available
Dr. Anne Elizabeth Borgman-Hagey M.D.
Chief Medical Officer
No Bio Available
Ms. Jane Chung R.Ph.
President & COO
No Bio Available
Dr. James R. Swartz DSc, Ph.D., Sc.D.
Founder
No Bio Available
Mr. Edward C. Albini M.B.A
CFO & Secretary
No Bio Available
Dr. Venkatesh Srinivasan Ph.d.
Chief Technical Operations Officer
No Bio Available
Mr. David Pauling J.D., M.A.
General Counsel
No Bio Available
Ms. Linda A. Fitzpatrick
Chief People & Communications Officer
No Bio Available
Dr. Barbara Leyman Ph.D.
Chief Business Development Officer
No Bio Available

Contacts

Address
CALIFORNIA
South San Francisco
111 Oyster Point Blvd.
Contacts
+16503928412.0
www.sutrobio.com